secwatch.observer — SEC 8-K summary
======================================

Issuer:     DSwiss Inc (DQWS)
CIK:        0001652561
Form:       8-K
Filed at:   2023-01-20T23:59:59+00:00
Accession:  0001493152-23-001963
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.15
Item codes: 2.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DSwiss (HK) acquires remaining 60% of DSwiss Biotech for nominal RM1
--------------------------------------------------------------------

- Acquired 150,000 shares (60%) of DSwiss Biotech Sdn Bhd from shareholder Jervey Choon on Jan 18, 2023.
- Purchase price: nominal fee of RM1 (approx. $0.23).
- DSBT supplies biotech products in Malaysia with in-house R&D.
- DSwiss (HK) now owns 100% of DSBT; acquisition closed as of Jan 18, 2023.
- No material financial impact disclosed; consideration is trivial.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652561/000149315223001963/0001493152-23-001963-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652561/000149315223001963/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-001963

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer